Bernard NF - Search Results

1

NK Cells in Protection from HIV Infection.

Bernard NF, Alsulami K, Pavey E, Dupuy FP. Bernard NF, et al. Viruses. 2022 May 25;14(6):1143. doi: 10.3390/v14061143. Viruses. 2022. PMID: 35746615 Free PMC article. Review.

2

Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection.

Alter G, Hatzakis G, Tsoukas CM, Pelley K, Rouleau D, LeBlanc R, Baril JG, Dion H, Lefebvre E, Thomas R, Côté P, Lapointe N, Routy JP, Sékaly RP, Conway B, Bernard NF. Alter G, et al. Among authors: bernard nf. J Immunol. 2003 Jul 1;171(1):477-88. doi: 10.4049/jimmunol.171.1.477. J Immunol. 2003. PMID: 12817033

3

Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infection.

Alter G, Tsoukas CM, Rouleau D, Côté P, Routy JP, Sékaly RP, Bernard NF. Alter G, et al. Among authors: bernard nf. AIDS. 2004 Oct 21;18(15):1979-89. doi: 10.1097/00002030-200410210-00002. AIDS. 2004. PMID: 15577619

4

Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.

Boulet S, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. Boulet S, et al. Among authors: bernard nf. AIDS. 2008 Mar 12;22(5):595-9. doi: 10.1097/QAD.0b013e3282f56b23. AIDS. 2008. PMID: 18317000

5

A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.

Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. Boulet S, et al. Among authors: bernard nf. AIDS. 2008 Jul 31;22(12):1487-91. doi: 10.1097/QAD.0b013e3282ffde7e. AIDS. 2008. PMID: 18614872

6

Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.

Huang KH, Loutfy MR, Boulet S, Toma E, Tsoukas CM, Bernard NF. Huang KH, et al. Among authors: bernard nf. Antivir Ther. 2009;14(3):381-92. Antivir Ther. 2009. PMID: 19474472

7

HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.

Boulet S, Song R, Kamya P, Bruneau J, Shoukry NH, Tsoukas CM, Bernard NF. Boulet S, et al. Among authors: bernard nf. J Immunol. 2010 Feb 15;184(4):2057-64. doi: 10.4049/jimmunol.0902621. Epub 2010 Jan 8. J Immunol. 2010. PMID: 20061407

8

Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.

Parsons MS, Boulet S, Song R, Bruneau J, Shoukry NH, Routy JP, Tsoukas CM, Bernard NF. Parsons MS, et al. Among authors: bernard nf. J Infect Dis. 2010 Nov 1;202 Suppl 3:S356-60. doi: 10.1086/655966. J Infect Dis. 2010. PMID: 20887224

9

Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.

Kamya P, Boulet S, Tsoukas CM, Routy JP, Thomas R, Côté P, Boulassel MR, Baril JG, Kovacs C, Migueles SA, Connors M, Suscovich TJ, Brander C, Tremblay CL, Bernard N; Canadian Cohort of HIV Infected Slow Progressors. Kamya P, et al. J Virol. 2011 Jun;85(12):5949-60. doi: 10.1128/JVI.02652-10. Epub 2011 Apr 6. J Virol. 2011. PMID: 21471235 Free PMC article.

10

HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.

Parsons MS, Wren L, Isitman G, Navis M, Stratov I, Bernard NF, Kent SJ. Parsons MS, et al. Among authors: bernard nf. J Virol. 2012 Apr;86(8):4488-95. doi: 10.1128/JVI.06112-11. Epub 2012 Feb 15. J Virol. 2012. PMID: 22345455 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page